Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases.
Takahashi S, Kinuya S, Nonomura N, Shinohara N, Suzuki K, Suzuki H, Nakamura K, Satoh T, Tateishi U, Yoneda T, Horikoshi H, Igawa T, Kamai T, Koizumi M, Kosaka T, Matsubara N, Miyake H, Mizokami A, Mizowaki T, Nakamura N, Nozawa M, Takahashi T, Uemura H, Uemura M, Yokomizo A, Yoshimura M, Kakehi Y. Takahashi S, et al. Among authors: igawa t. Oncol Ther. 2018 Dec;6(2):157-171. doi: 10.1007/s40487-018-0088-0. Epub 2018 Dec 11. Oncol Ther. 2018. PMID: 32700033 Free PMC article.
Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
Early primary renal tumor response predicts clinical outcome in patients with primary unresectable renal cell carcinoma with synchronous distant metastasis receiving molecularly targeted therapies.
Ueda K, Suekane S, Nishihara K, Suekane H, Ogasawara N, Kurose H, Chikui K, Ejima K, Suyama S, Nakiri M, Matsuo M, Igawa T. Ueda K, et al. Among authors: igawa t. Mol Clin Oncol. 2017 Aug;7(2):205-210. doi: 10.3892/mco.2017.1294. Epub 2017 Jun 15. Mol Clin Oncol. 2017. PMID: 28781786 Free PMC article.
Survival outcomes of non-definitive therapy for muscle-invasive bladder cancer.
Nishihara K, Ueda K, Kurose H, Ogasawara N, Hiroshige T, Chikui K, Ejima K, Uemura K, Nakiri M, Suekane S, Igawa T. Nishihara K, et al. Among authors: igawa t. Oncol Lett. 2022 Apr;23(4):126. doi: 10.3892/ol.2022.13246. Epub 2022 Feb 17. Oncol Lett. 2022. PMID: 35261639 Free PMC article.
Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer.
Hiroshige T, Eguchi Y, Yoshizumi O, Chikui K, Kumagai H, Kawaguchi Y, Onishi R, Hayashi T, Watanabe K, Mitani T, Saito K, Igawa T. Hiroshige T, et al. Among authors: igawa t. Oncol Lett. 2018 May;15(5):6806-6814. doi: 10.3892/ol.2018.8263. Epub 2018 Mar 14. Oncol Lett. 2018. PMID: 29725416 Free PMC article.
414 results